CMPS

NASDAQStock

COMPASS Pathways plc

$6.70-0.19 (-2.76%)

52-Week Range

$2.35

$8.45

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.98

Volume

1.5M

Avg Volume

3.2M

Performance

+5.41%

-1.63%

+28.99%

YTD

+1.22%

+77.75%

-18.05%

-84.35%

Price Chart

ETF Exposure

CMPS is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PSIL	AdvisorShares Psychedelics ETF	10.22%	255,739	$2.1M	$20.4M	1.84%
ARKG	ARK Genomic Revolution ETF	2.14%	3,199,815	$23.8M	$1.16B	0.75%
SURI	Simplify Propel Opportunities ETF	1.55%	159,052	$1.2M	$76.5M	2.82%
BBC	Virtus Biotech Clinical Trials ETF	0.82%	42,841	$319K	$39.0M	0.65%
GWX	State Street SPDR S&P International Small Cap ETF	0.07%	80,442	$583K	$865.1M	0.40%
IBBQ	Invesco Nasdaq Biotechnology ETF	0.05%	5,259	$39K	$74.5M	0.19%
IBB	iShares Biotechnology ETF	0.05%	524,508	$3.9M	$8.50B	0.44%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.04%	4,231	$31K	$86.8M	1.19%

About CMPS ETF Exposure

COMPASS Pathways plc (CMPS) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $6.70. Investors can gain exposure to CMPS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CMPS, sorted by portfolio weight.